WanderRx
Privacy-first medication management — GoodRx FTC settlement, NLM drug interaction API discontinued Jan 2024, pharmacist refusal documentation.
Health & WellnessAbout
GoodRx's FTC settlement confirmed what privacy researchers documented: the company shared your prescription data — including drug names, conditions, and dosages — with Facebook and Google for advertising. A subsequent $32M class action was dismissed in January 2026, meaning users have no civil remedy. The NLM Drug Interaction API, used by dozens of health apps as a free drug interaction database, was discontinued on January 2, 2024 — apps that relied on it have a drug interaction checking gap. WanderRx uses RxNav-in-a-Box and OpenFDA as local-first alternatives. Pharmacist refusal is a documented problem: trans people are refused HRT prescriptions in states with hostile pharmacy laws and refusal-of-care policies, often with no guidance on rights or alternatives. WanderRx documents refusals, logs the pharmacy's stated reason, and routes to the next affirming option. All data stays local — no prescription history sent to any server.
Features
- Cash price finder: no GoodRx account, no prescription data sold to advertisers
- Drug interaction checker: RxNav-in-a-Box + OpenFDA (NLM API discontinued Jan 2024 — we use what works)
- Pharmacist refusal documentation: log refusal, reason, date — route to affirming alternative
- Trans medication support: HRT, puberty blockers, cross-hormone therapy refill tracking
- Refill tracking + reminders — medication adherence without surveillance
- Controlled substance tracking: documentation without creating data broker records
- Insurance prior auth tracking: what's stuck, what to do next
- WanderHealthy integration: medication in your full health picture, local only
- All data on your device — no server, no data broker, no advertising SDK
- Medication savings programs: manufacturer coupons, assistance programs without GoodRx data sharing
Evidence-Based Design
This product's design is grounded in peer-reviewed research and validated practice.
- LGBTQ+ people have significantly higher medication non-adherence rates, driven by cost, stigma, fear of discovery, and housing instability. Kcomt et al. (2020). Healthcare avoidance due to anticipated discrimination. Social Science & Medicine. PMID 32113140PubMed: 32113140
- Generic PrEP (cabotegravir/rilpivirine) costs $30/month vs. $2,000+ for brand-name alternatives — a pricing gap most patients are never informed of. HIV.gov PrEP Medication Guide (2024)